NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
02/02/2026
Back to search
Official data from USPTO
LMK CLINICAL RESEARCH CONSULTING
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
30
Latest update
02/03/2026
Trademark type
Combined
Nice classes
35
Filing date
09/11/2015
Registration date
10/18/2016
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
02/02/2026
Last transaction
02/03/2026
Responsible office
United States Patent and Trademark Office
Status code
800
Official register
Principal Register
First use anywhere
06/01/2013
First use in commerce
06/01/2013
Drawing code
3
Owner type
16
Owner location
SAN JUAN, PR
Examiner
DUONG, ANGELA GAW
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the letters "LMK" in sans-seriff font. To the right of these letters are the words "Clinical Research Consulting" which are stacked such that "Clinical" appears above "Research" which appears above "Consulting". Between "LMK" and "Clinical Research Consulting" is an image of multiple circles stacked to resemble a twisting DNA molecule.
Holders and representatives
Holders
TRANSPERFECT TECHNOLOGIES LLC
LMK Clinical Research Consulting LLC
Representatives
Jason H. Kasner Lerner David LLP
Technical classification
Nice Classes
Class 35
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting and process assessment services in the nature of providing information management services in the field of document management in clinical research trials
Publications
History of USPTO decisions and trademark events.
30 publications found
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
02/02/2026
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
02/02/2026
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
01/26/2026
E89R
TEAS SECTION 8 & 9 RECEIVED
10/24/2025
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
10/18/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
02/09/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
02/09/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
02/09/2024
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
04/25/2023
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
04/25/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
04/25/2023
E815
TEAS SECTION 8 & 15 RECEIVED
10/17/2022
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
09/07/2022
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
10/18/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
10/18/2016
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
08/02/2016
PUBO
PUBLISHED FOR OPPOSITION
08/02/2016
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
07/13/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
06/29/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/28/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/27/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/27/2016
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/04/2016
GNRT
NON-FINAL ACTION E-MAILED
01/04/2016
CNRT
NON-FINAL ACTION WRITTEN
01/04/2016
DOCK
ASSIGNED TO EXAMINER
12/28/2015
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
09/17/2015
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
09/16/2015
NWAP
NEW APPLICATION ENTERED
09/15/2015
Continuous trademark protection
Get notified about every new filing that threatens LMK CLINICAL RESEARCH CONSULTING or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.